smita-pattnaik

Team member and collaborators

Current team members

Sumit Dey

PhD Scholar, DBT Fellow

Specializing in bladder cancer research. With a focus on drug repurposing, Mr. Dey aims to explore the potential of repurposing anticancer drugs to treat bladder cancer. His innovative research approach holds promise for identifying new therapeutic options and improving outcomes for patients with this challenging disease.

Sheetal Singh

PhD Scholar, CSIR-UGC fellow

Specializing in renal cell carcinoma research. With a primary focus on drug repurposing, she aims to investigate the potential of repurposing anticancer drugs for the treatment of renal cancers. Her research endeavors hold promise for identifying innovative therapeutic approaches and improving outcomes for patients with clear cell carcinoma.

Ritika

PhD Scholar, ICMR-SRF

Dedicated PhD scholar and ICMR fellow specializing in renal transplantation research. Her current research focuses on identifying pharmacodynamic biomarkers involved in renal transplantation patients, a critical aspect of successful renal transplantation. Through her meticulous investigations, Ms. Ritika aims to enhance our understanding of the immune response in transplant patients, ultimately leading to improved patient outcomes and personalized immunosuppressive strategies.

Laxmi Gharti

GPAT(2019) Qualified Research fellow

Dedicated team of researchers focusing on drug formulation. With a strong commitment to improving therapeutic options, they are currently engaged in developing innovative drug formulations specifically tailored for renal transplant recipients. Their research aims to enhance drug delivery methods, optimize dosing regimens, and improve the efficacy and safety profiles of medications in this patient population. Through their work, they strive to advance the field of renal transplantation and contribute to better outcomes for patients in need.

Heena

Project assistant

A dedicated team of researchers focusing on drug formulation. With a strong commitment to improving therapeutic options, they are currently engaged in developing innovative drug formulations specifically tailored for renal transplant recipients. Their research aims to enhance drug delivery methods, optimize dosing regimens, and improve the efficacy and safety profiles of medications in this patient population. Through their work, they strive to advance the field of renal transplantation and contribute to better outcomes for patients in need.

Kumaravel J

DM resident

A dedicated DM student whose research focuses on the pharmacokinetics (PK) and pharmacodynamics (PD) of drugs in Acute Myeloid Leukemia (AML). Dr. Kumaravel`s work aims to optimize drug dosing regimens and enhance treatment outcomes for individuals with this challenging hematological malignancy.

Ashwin Kumar

MD resident

An MD student with a passion for pharmacology. Although the specific focus of their research is yet to be determined, Dr. Ashwin actively participates in departmental routine activities and curriculum. With his enthusiasm, he is poised to make valuable contributions to the field of pharmacology and advance our understanding of drug interactions and therapeutic interventions.

Alumni team members

Priyanka Naithani

PhD (2017-2022)

Priyanka, an esteemed alumni who has conducted research on the pharmacogenomics of renal transplantation patients. With a focus on personalized medicine, she explored the genetic factors influencing drug response and toxicity in the context of renal transplantation. Her work has contributed to the understanding of individualized treatment approaches, optimizing drug selection and dosing strategies to improve patient outcomes and minimize adverse effects.

Neeru Sharma

M.Sc (2019-2021)
Current status: Pharmacist AAMC,Patiala

MSc student from 2019 to 2021, Neeru dedicated her studies to developing an animal model of bladder cancer as part of her MSc dissertation. Not only did she successfully create the model, but she also explored innovative treatments for bladder cancer within her research.

Neha Dhir

M.Sc (2014-2016)
Current status: PhD from PGIMER

made significant contributions to the field of neuroscience, with a specialization in Aneurysmal Subarachnoid Haemorrhage (aSAH). Her MSc dissertation focused on in-depth research and analysis of this complex neurological disorder. Neha has since completed her PhD, further expanding her expertise in the field of neuroscience. Her continued dedication to research and education demonstrates her unwavering commitment to advancing scientific knowledge and making a positive impact in the medical community.

Dr. Bhaskar Krishnamurthy

DM resident (2016-2019)
Current status: Assistant Professor Department of Clinical Pharmacology Seth GSMC and KEM Hospital Mumbai

Dr. Bhaskar, an accomplished DM who worked under the guidance of Dr. Smita Pattanaik. His research centred around the use of mycophenolic acid in renal transplantation patients. He demonstrated the importance of therapeutic drug monitoring (TDM). Currently, Dr. Bhaskar serves as an assistant professor at the Department of Clinical Pharmacology, Seth GSMC, and KEM Hospital in Mumbai. His expertise and research contributions continue to advance the field of pharmacology and personalized medicine in patient care.

Dr. Varnit Kaushik

MD Resident (2019-2022)
Current status: pursuing DM AIIMS, Delhi

An accomplished MD Resident under the supervision of Dr. Smita in the field of pharmacoeconomics. His work focused on evaluating the economic impact of pharmaceutical interventions, providing valuable insights into cost-effectiveness and resource allocation in healthcare. He contributed to evidence-based decision-making, optimizing patient outcomes while considering the financial aspects of healthcare delivery.

Dr. Rachna

MD Resident (2018-2020)
Current status: Assistant Professor AIIMS Bhatinda

MD Resident, conducted research on chronic kidney disease stages 3 and 4, specifically focusing on the use of drugs such as propofol and ketofol. Her work aimed to assess the safety and efficacy of these medications in patients with impaired kidney function, providing valuable insights for optimizing anaesthesia management in this population.

Ritu Singh

Juniour research fellow 2018-2019
Current status: Pursuing PhD Texas A&M University Collegestation, Texas

as JRF staff members, played instrumental roles in a clinical Phase 2/3 trial focused on evaluating the efficacy and safety of repurposed drug Hydroxychloroquine (HCQ) in combination with first line therapies for the treatment of Muscle-Invasive Bladder Cancer (MIBC). Their dedicated efforts encompassed various aspects, including patient recruitment, data collection, and monitoring adverse events. By exploring the potential of HCQ in combination therapy, their work contributes to the advancement of treatment options for MIBC patients.

Dikshu jaryal

Dikshu jaryal Juniour research fellow 2020-2021
Current Status: employ at Wockhardt

Shalini Raik

Juniour research fellow 2016
Current status: PhD from PGIMER

Shalini, Navjit, and Rohit collaborated on a DBT-funded project centred around bladder cancer research. Their primary objective was to isolate and cultivate cells from urine samples, to study the disease at a cellular level. Their dedicated efforts in this project provide valuable insights into the development of non-invasive diagnostic methods and personalized treatment strategies for bladder cancer patients.